GlassScriptPhysician profile
Hina N Dave
NPI 1750543328
$48,146.54
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $373 · 2021: $129 · 2022: $6,516 · 2023: $21K · 2024: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15K · Travel and Lodging: $5,096 · Food and Beverage: $3,517 · Education: $1.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,434.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15,080.00 |
| Travel and Lodging | $5,095.85 |
| Food and Beverage | $3,517.09 |
| Education | $1.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $36,281.72 | 2022-2024 | Briviact, Fintepla, Nayzilam |
| Neurelis, INC. | $5,708.23 | 2023-2024 | Valtoco |
| Medtronic, INC. | $2,859.12 | 2022-2024 | Percept PC Brainsense, Activa PC |
| Neuropace, INC. | $1,973.35 | 2019-2024 | |
| Sk Life Science, INC. | $354.91 | 2022-2023 | Xcopri |
| Jazz Pharmaceuticals INC. | $259.86 | 2022-2024 | Epidiolex |
| Greenwich Biosciences, INC. | $237.55 | 2019 | |
| Sumitomo Pharma America, INC. | $150.22 | 2023-2024 | Aptiom |
| Silk Road Medical, INC. | $97.30 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Pulmonx Corporation | $91.69 | 2024 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Catalyst Pharmaceuticals, INC. | $48.78 | 2023 | Fycompa |
| Monteris Medical Corporation | $34.13 | 2019 | |
| Janssen Pharmaceuticals, INC | $25.00 | 2023 | Xarelto |
| Livanova USA, INC. | $24.68 | 2023 | Vns Therapy Sentiva Model 1000 Generator |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hina Dave listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.